AmphiStar funding news – Belgian-based AmphiStar Received a €2 Million Non-Dilutive Grant from SPRIN-D
Oct 21, 2024 | By Oliver Bennett

Biotech startup AmphiStar, a leader in sustainable surfactant products, has recently been awarded a €2 million non-dilutive grant from SPRIN-D (Federal Agency for Disruptive Innovation).
SUMMARY
- Biotech startup AmphiStar, a leader in sustainable surfactant products, has recently been awarded a €2 million funding
- AmphiStar leads the circular economy with innovative biotechnology, creating sustainable, high-performance products for personal care, home care, and industrial sectors.
This brings the total funding secured by the Belgian innovator to €10 million this year. AmphiStar’s biotechnology platform utilizes synthetic biology to develop custom molecules that meet specific performance requirements.
These tailor-made biosurfactants, derived from organic waste and side streams, not only provide an environmentally friendly alternative to conventional chemically produced surfactants (fossil- and biobased) and other commercial microbial biosurfactants, but also open up new opportunities for innovation in the cleaning, cosmetics, and personal care industries.
RECOMMENDED FOR YOU
Polish VC Firm Movens Capital Launches €60 Million To Back Startups
Kailee Rainse
Jun 23, 2025
[Funding alert] London-based Fyde Treasury Secures $3.2M in Seed Funding
Oliver Bennett
Dec 23, 2023
The grant is part of a highly competitive multi-stage funding program supported by the German government, and it will aid in furthering the development of AmphiStar's advanced biotechnology platform. Previously, the company received €1.5 million in the program’s initial phase last year and is currently in the running for an additional €2 million in the final round of funding, which will be awarded next year to the top two performing teams.
Pierre-Franck Valentin, CEO of AmphiStar, said, "With the freedom that non-dilutive funding provides, we can continue to develop and refine our bespoke, sustainable surfactants that meet the growing demand for high-performance, eco-friendly solutions in personal- and home care. This support reinforces the German government’s recognition of our breakthrough technology and its potential to revolutionize the industry."
Sophie Roelants, Co-founder and COO of AmphiStar, said, "This grant enables us to concentrate on developing entirely new, promising molecules at low technology readiness levels (TRL), all produced from waste through a continuous biomanufacturing process. Our goal is to reduce costs and enhance sustainability while maintaining functionality, aligning perfectly with our mission to replace traditional surfactants with environmentally responsible, bio-based alternatives — without compromising on quality or affordability."
About AmphiStar
AmphiStar leads the circular economy with innovative biotechnology, creating sustainable, high-performance products for personal care, home care, and industrial sectors.
Recommended Stories for You
HERO Software funding news – Hannover-based HERO Software Sercures €40Million in a Series B Round Funding
Oliver Bennett Jul 12, 2024






